H.R. 198 · 118th Congress
Drug Pricing Transparency and Accountability Act
- Stage
- In committee
- Sponsor
- Matthew Rosendale
- Introduced
- 2023-01-09
- Latest action
- 2024-12-17 · Referred to the Subcommittee on Health.
Subjects
Medicare
Administrative law and regulatory procedures
Congressional oversight
Public contracts and procurement
Government studies and investigations
Health
Health information and medical records
Medicaid
State and local government operations
Health facilities and institutions
Home and outpatient care
Department of Health and Human Services
Government information and archives
Public-private cooperation
Prescription drugs
Hospital care